Cambridge, Massachusetts-based biotech Regor Therapeutics Group has agreed to sell its portfolio of CDK inhibitors for the treatment of breast cancer to Roche's Genentech for an upfront cash ...

Per the agreement, Roche’s Genentech will acquire Regor’s portfolio of next-generation CDK inhibitors for the treatment of breast cancer. The purchase agreement was announced at Roche’s ...

Catch up on all the biggest pharma news to hit the industry last month, spanning from new acquisitions, insights on the NHS ...

CDK Global reportedly paid $25 million to cybercriminals after a mid-June ransomware attack disrupted business for thousands of car dealerships. According to a report from CNN citing multiple ...

A pair of cyberattacks against software maker CDK continues to impact thousands of car dealerships and has spurred threat actors to launch impersonation attacks. The CDK Global outage affecting ...

But since that day, it's a lot more significant as CDK Global continues to recover from the devastating cyberattack that disrupted auto sales and service operations at roughly 15,000 U.S ...

AUSTIN, Texas, October 07, 2024--(BUSINESS WIRE)--CDK, the leading automotive retail software provider, today announced a long-term extension of its agreement with AutoCanada Inc. (TSX ...

CDK Global has extended its dealership management system agreement with Sonic Automotive Inc., a win for the DMS provider in the wake of two June 19 cyberattacks that challenged customer loyalty ...

AUSTIN, Texas--(BUSINESS WIRE)--CDK, the leading automotive retail software provider, today announced the launch of the company’s new software certifications and courseware, designed to equip ...

AUSTIN, Texas, October 09, 2024--(BUSINESS WIRE)--CDK, the leading automotive retail software provider, will host its fourth annual CDK CONNECT on Tuesday, Oct. 22 at 11 a.m. CT. The virtual event ...

Per the agreement, Roche’s Genentech will acquire Regor’s portfolio of next-generation CDK inhibitors for the treatment of breast cancer. The purchase agreement was announced at Roche’s Pharma Day.